Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype
As we move past a phase of “partial eclipse” by psychedelic hype, this critical field is finally well-situated to explore the full spectrum of psychedelic effects.
Psychedelics & Drug Policy
-
Read more: Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype -
Read more: Psychedelic Law and U.S. Military Veterans Psychedelic Law and U.S. Military Veterans
RecordingEvent Description Military veterans and active-duty service members experience unique stressors and are heavily impacted by depression, post-traumatic stress disorder, and suicide. As part of the evolving psychedelic renaissance, researchers are exploring therapeutic interventions such as psilocybin, MDMA, and ibogaine. These substances produce profound changes of cognition, perception, and mood. Clinical trials suggest they may…
-
Read more: Organ Transplant Candidates Who Use Medical Cannabis Face Discrimination Organ Transplant Candidates Who Use Medical Cannabis Face Discrimination
Considering growing evidence that medical cannabis does not compromise post-transplant health outcomes, policymakers should rethink restrictions.
-
Read more: Psychedelics in the Global South Psychedelics in the Global South
RecordingEvent Description Interest in psychedelic research is growing internationally. Scientists are advancing our understanding of the chemistry and biology of psychedelics, as well as their effects on human health, psychology, and spirituality. News reports on psychedelics often emphasize countries of the Global North including the United States, Canada, Australia, and the United Kingdom. However, psychedelic…
-
Read more: Neuroscience and Cannabis: Implications for Law and Policy Neuroscience and Cannabis: Implications for Law and Policy
RecordingEvent Description The legalization of cannabis has raised significant questions for law and public policy. In this public event, neuroscientist Dr. Yasmin Hurd explored the science of cannabis, CBD, and the future of substance use disorder treatment. Dr. Stephanie Tabashneck then moderated a discussion and audience Q&A about the implications for law and policy. Panelists Slides…
-
Read more: Psychedelics in the Global North Psychedelics in the Global North
RecordingEvent Description In partnership with the RAND Drug Policy Research Center, the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center at Harvard Law School is pleased to present a virtual panel on Psychedelics in the Global North, the first of a three-part spring series. Other events in April and May discussed psychedelics in the…
-
Read more: Comparing Legal Approaches to Accessing Psychedelics Comparing Legal Approaches to Accessing Psychedelics
RecordingEvent Description Voters, lawmakers, and healthcare providers are experimenting with legal approaches to accessing psychedelics. Some take medical approaches by allocating funds for research or leveraging controversial federal policies like right-to-try or expanded access. Others reduce criminal penalties or create regulatory systems outside the federal framework, allowing access to psychedelics for promoting mental and physical…
-
Read more: Disclosed: Conflicts of Interest in the Psychedelics Ecosystem Disclosed: Conflicts of Interest in the Psychedelics Ecosystem
Event Description In recent years, a growing number of observers have raised concerns about conflicts of interests in the growing psychedelics industry. Beginning with a discussion of cases that have prompted calls for conflict of interest reform in psychedelics research and treatment, this panel will examine what it means to say that a therapist, researcher,…
-
Read more: Informed Consent in Psychedelic Therapy and Research: Why is it Complicated? Informed Consent in Psychedelic Therapy and Research: Why is it Complicated?
Event Description As psychedelics are quickly becoming implemented into the Western therapeutic medical model, ethical codes and boundaries are essential to ensure safe practices with these substances. An important topic when thinking about this is informed consent. What is the role of power dynamics in informed consent for psychedelic-assisted therapies and research? Can an explicit…
-
Read more: What Can the Psychedelics Industry Learn from Cannabis Regulation? What Can the Psychedelics Industry Learn from Cannabis Regulation?
RecordingEvent Description Psychedelics have recently become a serious topic of legal reform and intense commercial investment. In the past few years, dozens of cities and states have enacted or proposed legislation to decriminalize or regulate psychedelics like psilocybin, dimethyltryptamine, mescaline, and ibogaine. Meanwhile, billions of dollars are flowing into psychedelic companies that are researching, patenting,…
